News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ZMRK. 50% of the OS is owned by CEO + Insiders. Their largest investor, Frank La Salla is CEO of DTCC; a company valued at a total equity exceeding 2 billion. This is huge!! Still under the radar and at bottom with NO Notes + No Dilution!
|
Followers
|
160
|
Posters
|
|
|
Posts (Today)
|
2
|
Posts (Total)
|
26020
|
|
Created
|
10/16/12
|
Type
|
Free
|
| Moderators | |||
TORNONTO, ON / ACCESSWIRE / March 15, 2021 / Zalemark Holding Company Inc.(OTC PINK:ZMRK) signed Licensing Agreement with Lupos (Canada) Biotechnology Inc. to develop Cannabis topical products. This agreement will bring Zalemark in a position to market the cannabis products under their own registered "Aeroponleaf" trademark.
"We are excited to work with Lupos!" said Xia Wu, CEO of Zalemark. "Teaming up with Lupos to engage the cannabis topical products is an exciting development for our company".
"As a leading manufacturer of topicals products for the legal Canadian cannabis market, Lupos is thrilled to work with Zalemark to bring unique and innovative cannabis-based topicals to the Canadian market" said Dr. Nan Li, Founder and Chair of Lupos.
This agreement reflects Zalemark's desire to collaborate with companies that share the same visions of future of cannabis products. It also underscores Zalemark's commitment to its shareholders about cannabis products development.
Zalemark will be working closely to implement the plan. As the plan unfolds, the management team will deliver more information.
Forward Looking Statements
| PUBLISH DATE | TITLE | PERIOD END DATE | STATUS |
|---|---|---|---|
| 07/09/2021 | Attorney Letter with Respect to Current Information - 2021 Q1 Attorney letter | 03/31/2021 | A |
| 07/08/2021 | Quarterly Report - 2021 Q1 rev | 03/31/2021 | A |
| 07/08/2021 | Annual Report - 2020 Annual Report rev | 12/31/2020 | A |
| 07/08/2021 | Quarterly Report - 2020 Q3 rev | 09/30/2020 | A |
| 07/25/2020 | Quarterly Report - Zalemark 2020 Q2 Rev 1 | 06/30/2020 | A |
| 05/22/2020 | Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information | 12/31/2019 | A |
| 05/14/2020 | Quarterly Report - 2020 Q1 | 03/31/2020 | A |
| 05/14/2020 | Annual Report - 2019 Annual Report | 12/31/2019 | A |
| 10/24/2019 | Quarterly Report - 2019 Q3 | 09/30/2019 | A |
| 10/03/2019 | Attorney Letter with Respect to Current Information - 2018 Annual Report | 12/31/2018 | A |
